IDiyas

For the Inventor, By the Inventor

Suffern, NY, United States of America

Donald B Borders

USPTO Granted Patents = 33

Average Co-Inventor Count = 4.0

ph-index = 6

Forward Citations = 105(Granted Patents)


Location History:

  • Rockland, NY (US) (1989)
  • Suffern, NY (US) (1976 - 2014)

Company Filing History:

goldMedal24 out of 3,580 
 
American Cyanamid Company
 patents
silverMedal4 out of 11 
 
Micrologix Biotech Inc.
 patents
bronzeMedal3 out of 7 
 
Biosource Pharm, Inc.
 patents
4. 1 out of 20 
 
Migenix, Inc.
 patents
5. 1 out of 1 
 
Biowest Therapeutics Inc.
 patent

Years Active: 1976-2014

Loading Chart...
33 patents (USPTO):Explore Patents
1. 8889826 - Peptide antibiotics and methods for making same (2014-11-18),
2. 7868135 - Compositions of lipopeptide antibiotic derivatives and methods of use thereof (2011-01-11),
3. 7138487 - Extractive purification of lipopeptide antibiotics (2006-11-21),
4. 6767718 - Lipodepsipeptide antibiotics and methods of preparation (2004-07-27),
5. 6750199 - Antimicrobial sulfonamide derivatives of lipopeptide antibiotics (2004-06-15),
6. 6737403 - Derivatives of laspartomycin and preparation and use thereof (2004-05-18),
7. 6716962 - Extractive purification of lipopeptide antibiotics (2004-04-06),
8. 6613889 - Method for preparing salts of polyene macrolide esters (2003-09-02),
9. 6511962 - Derivatives of laspartomycin and preparation and use thereof (2003-01-28),
10. 5077277 - Chemical derivatives of antibiotics LL-E19020 alpha and beta (1991-12-31),
11. 4968493 - Method for controlling chronic respiratory disease, fowl cholera and (1990-11-06),
12. 4870019 - Antibiotic LL-C19004 (1989-09-26),
13. 4859598 - Antibiotic LL-D42067.beta. (1989-08-22),
14. 4845037 - Process for producing antibiotic LL-D42067.alpha. (1989-07-04),
15. 4774184 - Culture and process for producing antibiotic LL-D42067alpha (1988-09-27),

Title: The Innovative Journey of Donald B. Borders

Introduction

Donald B. Borders, based in Suffern, NY, is an accomplished inventor with 33 patents to his name. His innovative contributions primarily focus on peptide antibiotics, demonstrating a significant impact on the pharmaceutical field.

Latest Patents

Among his recent inventions, Borders has developed novel peptides and protected peptides derived from naturally occurring sources such as colistin, circulin A, polymyxin, and octapeptins. These peptide compounds promise advancements in antimicrobial treatment. Additionally, he has created derivatives of lipopeptide antibiotics that exhibit antimicrobial activity, along with methods for synthesizing these compounds, aimed at combating microbial infections effectively.

Career Highlights

Borders has had a notable career, contributing his expertise in various roles. He worked at reputable organizations, including the American Cyanamid Company and Micrologix Biotech Inc., where he applied his knowledge to drive innovation in medicinal chemistry and antimicrobial solutions.

Collaborations

Throughout his career, Borders has collaborated with distinguished colleagues such as Raymond T. Testa and David P. Labeda. These partnerships have facilitated advancements in research and the development of effective therapeutic agents, showcasing the power of teamwork in scientific exploration.

Conclusion

Donald B. Borders exemplifies the spirit of innovation with his extensive portfolio of patents and impactful contributions to the field of peptide antibiotics. His work continues to inspire future generations of inventors in the ongoing fight against microbial threats.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…